rfhg_127594.1

Basic information about the TSS

---

TSS ID: rfhg_127594.1 Species: human Chr: chr10		Start: 80173016 End: 80173025 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2366597,EH38E1483075)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000437799.1:0 GeneID: 311 HGNC/MGI_ID: HGNC:535 UniProt_ID: Q5T0G7 Nearer transcript ids and distances: ENST00000265447.8:145 DQ893503:152 DQ896481:152 AB385060:153 BT019934:155 CR450323:155 view more...

Gene_name: annexin A11 Gene_symbol: ANXA11 Gene_synonyms: Gene_source: HGNC:535

TATA-Box annotation

---

Distance to TSS:	31471
Nearest PromoterID:	NM_001278408
Entrez ID:	311
Nearest Unigene:	Hs.530291
Nearest Refseq:	NM_001157
Nearest Ensembl:	ENSG00000122359
Gene Name:	annexin A11
Gene Alias:	ALS23|ANX11|CAP-50|CAP50
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.400000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANXA11 p2@ANXA11 p3@ANXA11 p5@ANXA11 p6@ANXA11 p7@ANXA11
Sample		p1@ANXA11	p2@ANXA11	p3@ANXA11	p5@ANXA11	p6@ANXA11	p7@ANXA11
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	41.10	12.86	1.95	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	47.95	13.56	1.42	0.61	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.42	15.24	1.74	0.39	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	36.59	7.90	1.46	0.42	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	41.39	9.00	0.67	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.21	11.24	0.97	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	49.90	13.73	1.31	0.44	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	45.05	13.08	0.73	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	50.65	17.74	1.28	0.21	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	10.43	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.85	7.68	0.81	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	44.31	4.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	130.57	88.49	5.96	1.61	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	99.08	65.10	3.91	1.50	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	113.29	73.33	1.54	2.20	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	108.64	73.18	2.01	2.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	109.86	66.18	1.97	1.53	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	101.66	62.01	2.95	1.69	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	89.57	65.04	2.67	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	94.18	65.14	3.16	1.05	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	102.78	66.83	1.20	1.20	0.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	83.03	59.90	3.80	1.04	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	94.49	61.40	2.71	1.68	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	98.04	60.18	2.91	1.21	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	120.22	62.69	1.55	1.55	0.77	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	105.08	64.25	4.11	0.63	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	99.45	56.04	3.30	0.00	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	105.38	76.15	4.01	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	97.40	59.60	1.94	0.81	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	95.91	52.84	2.17	1.27	0.18	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	100.07	63.64	2.93	1.05	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	100.04	62.91	2.93	1.37	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	113.53	59.51	2.95	0.42	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	67.96	52.29	4.62	0.49	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	98.73	61.33	3.37	1.50	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	115.55	66.30	2.30	1.34	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	101.58	57.43	3.47	0.61	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	100.54	57.42	4.23	1.21	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	106.15	64.28	4.05	1.08	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	89.06	54.73	2.64	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	101.63	56.70	2.35	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	68.37	44.21	3.22	1.02	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	97.43	60.53	2.11	1.48	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	109.79	71.15	3.15	0.35	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	99.98	59.83	4.02	0.60	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	102.36	59.79	3.26	1.63	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	102.68	68.13	2.40	0.96	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	86.43	64.68	1.49	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	94.31	69.66	3.11	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	86.34	56.82	4.04	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	72.96	55.54	4.30	0.41	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	93.84	59.82	2.89	0.89	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	80.91	52.52	3.19	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	64.95	49.71	2.98	1.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	39.43	29.36	0.84	5.03	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.49	33.98	3.21	0.46	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	58.34	50.24	2.59	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	79.65	65.84	0.96	0.32	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.41	35.52	3.14	0.31	0.00	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	59.93	45.12	2.12	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.67	37.57	1.68	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	44.58	43.79	6.37	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.05	28.54	1.70	1.02	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	64.98	54.91	0.65	0.32	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	66.74	45.44	1.06	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	48.49	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	67.76	43.39	0.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	46.61	32.23	1.49	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	43.16	27.21	2.81	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	46.37	39.08	2.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	68.36	51.35	5.26	0.93	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	74.30	53.20	2.45	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	105.01	39.75	3.01	1.11	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	121.28	37.86	5.78	1.44	0.32	0.80
Adipocyte - omental, donor1	11473-119C6	117.18	40.33	3.69	1.15	1.15	0.89
Adipocyte - omental, donor2	11474-119C7	136.79	40.36	5.98	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	133.97	39.52	2.68	2.01	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	141.00	24.88	2.55	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	53.88	29.69	1.10	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	126.45	29.36	4.06	0.45	0.45	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	99.57	41.88	2.26	1.22	0.35	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	102.87	43.03	2.54	0.98	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	60.48	28.05	0.77	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	163.64	57.43	4.46	1.39	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	142.84	51.14	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	104.24	27.83	1.69	0.56	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	121.36	32.28	0.97	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	114.64	34.66	1.07	2.13	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	144.67	31.16	2.23	0.56	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	100.65	21.21	1.66	1.25	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	105.24	29.14	0.75	1.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	125.66	23.56	2.29	0.65	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	107.78	21.92	1.22	1.52	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	182.99	42.43	1.77	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	349.98	57.37	6.10	1.43	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	121.00	51.51	0.00	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	126.11	43.18	0.72	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	123.84	55.23	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	151.00	54.03	1.64	0.62	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	336.30	76.44	3.32	0.92	0.46	0.46
Anulus Pulposus Cell, donor2	11463-119B5	308.83	56.57	2.69	0.49	0.98	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	67.39	25.61	2.70	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	83.79	32.13	1.74	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	57.79	55.65	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	70.25	25.71	2.09	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	65.76	36.67	2.53	1.26	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	67.33	36.30	2.64	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	65.63	28.27	0.97	0.00	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	68.93	33.50	0.00	0.00	2.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	65.92	29.69	3.56	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	67.04	27.12	1.88	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	74.02	27.58	1.45	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	55.17	30.09	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	76.27	36.90	0.66	0.00	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	79.16	30.03	0.00	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	43.28	28.50	1.21	0.15	1.66	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	79.30	21.43	0.54	0.54	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	78.41	38.16	1.32	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	80.19	35.28	3.74	0.27	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	82.91	31.21	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	68.67	32.84	1.16	0.17	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	61.24	30.02	1.20	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	123.91	21.24	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	78.39	36.71	0.69	0.34	0.86	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	29.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	60.68	31.07	2.91	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	77.79	33.39	1.14	0.38	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	77.53	44.82	1.21	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	58.71	18.81	1.14	0.00	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	71.83	31.64	1.50	0.00	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	65.04	37.94	1.29	0.00	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	78.83	28.62	1.41	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	77.49	35.37	2.57	0.32	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	69.92	40.67	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	67.27	28.08	1.17	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	72.26	35.83	0.90	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	76.03	38.02	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	77.81	20.85	2.03	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	68.00	37.44	1.27	0.25	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	62.90	32.40	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	69.91	22.87	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	75.78	32.60	1.06	0.21	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	66.12	33.35	1.16	0.29	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	70.86	26.45	2.83	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	64.59	33.06	0.68	0.68	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	74.12	44.01	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	114.08	29.58	4.23	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	70.33	35.16	0.86	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	77.01	40.31	2.41	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	59.78	21.14	1.46	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	71.49	38.39	0.92	0.46	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	33.15	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.63	21.61	0.25	0.00	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	71.22	37.98	1.45	0.21	1.45	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	67.01	30.60	1.53	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	69.79	21.03	1.43	0.96	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	68.07	30.60	0.44	0.22	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	22.89	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	55.39	17.72	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	62.76	27.80	0.53	0.26	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.25	30.53	2.18	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	254.72	59.69	1.72	0.49	0.74	0.00
Astrocyte - cerebellum, donor2	11580-120F5	338.73	87.12	3.94	1.20	1.88	0.34
Astrocyte - cerebellum, donor3	11661-122F5	109.07	52.02	1.26	0.84	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	51.24	32.42	0.70	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	96.26	38.83	2.26	0.81	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	65.48	42.06	1.34	0.75	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	105.17	90.03	2.87	0.46	0.34	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	100.48	87.70	1.50	0.38	0.38	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	91.72	81.48	1.14	0.23	0.11	0.00
Basophils, donor1	12241-129G9	102.00	54.66	0.78	0.00	1.57	0.26
Basophils, donor2	12242-129H1	69.99	41.85	0.36	0.36	0.36	0.00
Basophils, donor3	12243-129H2	88.79	54.54	0.29	0.73	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	61.45	18.97	0.22	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	183.79	59.89	3.66	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	165.07	23.85	2.51	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	127.27	33.27	3.12	0.62	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	92.35	32.70	2.30	0.69	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	41.39	17.81	1.08	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	14.22	3.19	0.10	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	35.17	22.59	0.47	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	47.33	53.40	0.32	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	51.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	95.80	50.16	0.00	0.56	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	121.20	69.23	1.30	0.37	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	108.45	53.57	0.88	0.44	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	95.95	94.25	6.51	0.57	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	161.11	102.35	5.31	1.14	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	126.57	96.98	3.62	0.99	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	164.79	81.53	7.08	1.73	2.02	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	131.26	50.69	3.32	0.91	2.11	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	143.08	58.04	3.79	0.95	1.66	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	127.56	59.93	2.18	1.17	2.01	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	120.89	39.75	2.21	0.55	4.97	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	124.71	36.45	1.49	1.24	4.96	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	212.64	66.18	5.68	0.98	2.94	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	197.46	44.16	2.85	1.25	4.10	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	157.56	38.30	2.83	0.65	2.83	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	95.29	52.91	3.04	1.17	2.11	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	137.82	45.41	1.58	1.06	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	110.94	42.16	2.22	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	142.50	63.96	4.61	1.34	2.53	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	118.93	33.52	3.19	0.60	4.59	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	99.94	24.57	1.25	0.21	1.04	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	123.77	65.66	4.58	0.92	2.75	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	112.20	35.97	2.26	0.45	2.49	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	96.89	36.23	3.06	0.44	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	342.15	78.55	8.07	1.61	3.77	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	257.68	56.70	7.15	1.74	4.88	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	292.05	68.59	5.47	0.00	6.73	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	88.36	53.46	1.65	0.37	1.10	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	94.05	39.45	2.11	0.70	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	76.78	34.66	0.88	0.00	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	200.01	51.44	4.01	1.57	12.73	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	203.31	54.26	2.97	0.74	7.43	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	159.51	47.64	3.45	0.65	7.54	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	92.54	48.73	3.28	0.41	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	79.97	33.61	0.46	0.23	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	60.09	22.04	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	67.57	43.16	1.96	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	89.86	53.59	1.85	0.00	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	76.68	45.49	0.87	0.22	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	121.93	92.97	1.40	1.56	0.78	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	117.88	89.24	1.75	0.52	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	122.41	79.38	3.34	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	66.09	37.26	0.26	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	81.02	44.13	0.66	0.00	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	62.74	37.48	0.84	0.21	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	113.81	34.55	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	115.93	28.48	2.03	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	130.49	20.71	1.04	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	134.33	28.78	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	167.79	29.48	1.07	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	113.01	24.57	1.40	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	125.50	25.88	0.78	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	127.87	31.64	3.95	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	131.50	29.59	2.47	1.64	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	143.63	29.74	0.73	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	137.82	30.79	1.01	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	4.85	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.19	3.20	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	43.17	32.13	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	60.11	34.27	0.00	0.00	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	52.61	45.47	0.75	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.10	59.53	0.68	0.45	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	188.17	30.71	0.71	0.71	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	207.59	32.46	3.06	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	210.75	35.99	3.66	0.61	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	267.74	36.50	5.36	1.02	1.79	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	275.36	48.29	3.82	1.12	0.67	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	297.23	65.54	3.74	1.72	1.15	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	232.78	22.28	1.90	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	221.23	20.37	0.70	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	309.85	23.07	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	172.70	54.77	4.05	0.87	0.29	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	233.01	57.45	3.90	1.19	0.17	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	201.67	55.62	2.90	0.64	0.97	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	217.87	37.21	1.34	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	237.23	36.34	1.40	1.40	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	227.91	35.64	3.52	1.32	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	185.52	60.29	3.37	0.42	0.84	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	171.62	92.25	1.66	1.87	0.62	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	171.74	72.84	3.34	1.34	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	258.88	34.54	2.99	0.82	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	248.68	28.41	2.68	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	272.57	19.73	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	224.92	55.81	2.97	0.74	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	171.99	41.81	2.38	0.65	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	192.29	48.97	1.89	0.84	0.42	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	177.47	28.31	0.51	1.52	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	200.16	35.96	3.47	0.87	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	156.46	22.23	2.18	0.87	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	217.74	37.61	2.47	1.48	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	184.64	36.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	164.71	26.52	1.40	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	220.71	35.45	4.15	0.28	0.28	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	259.13	40.24	3.93	0.49	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	235.62	32.34	3.08	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	209.86	37.60	2.86	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	181.43	27.70	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	165.66	22.26	1.96	0.33	0.65	0.65
CD8+ T Cells, donor2	11307-117C2	165.57	23.28	3.00	0.38	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	176.24	29.79	2.27	0.25	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	98.64	51.84	1.38	0.23	0.69	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	98.73	47.93	1.68	0.48	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	96.03	54.17	4.92	0.55	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	66.35	44.73	4.20	0.30	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	105.83	48.24	2.64	1.20	2.64	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	102.32	52.98	0.23	0.00	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	92.56	42.15	1.74	1.09	2.61	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	102.65	42.11	2.37	0.00	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	105.53	51.83	3.52	0.47	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	86.34	45.28	1.81	0.60	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	77.86	41.25	3.20	1.45	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	83.13	41.03	2.66	0.00	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	82.73	41.15	0.88	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	79.24	36.89	1.37	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	85.03	51.47	0.75	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	114.53	53.30	2.52	0.00	3.24	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	110.20	57.54	5.75	0.58	2.30	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	106.30	54.68	2.59	0.24	1.89	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	115.35	49.12	2.22	0.32	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	108.26	47.67	3.38	0.92	2.15	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	103.55	52.26	2.56	0.00	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	61.58	35.95	1.15	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	69.36	39.02	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	74.88	31.77	0.76	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	70.66	22.48	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	66.45	21.68	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	82.14	33.06	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	137.08	34.73	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	130.44	44.96	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	117.86	29.36	0.63	0.00	0.42	0.32
Chondrocyte - de diff, donor1	11261-116G1	210.43	28.77	2.43	1.39	1.73	0.69
Chondrocyte - de diff, donor2	11338-117F6	174.49	33.41	2.49	0.00	2.84	0.36
Chondrocyte - de diff, donor3	11410-118E6	178.63	42.10	2.28	0.80	1.14	0.23
Chondrocyte - re diff, donor2	11339-117F7	27.75	14.32	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	93.42	22.24	1.21	1.21	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	137.37	58.18	1.38	0.23	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	128.47	54.94	2.78	1.07	0.43	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	135.76	51.86	2.30	0.53	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	151.40	51.17	2.11	0.92	0.64	0.46
Corneal Epithelial Cells, donor1	11526-119I5	124.50	32.06	0.44	0.88	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	110.35	28.44	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	125.00	32.47	1.79	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	534.08	86.51	5.94	1.98	1.98	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	552.60	91.47	5.36	0.95	1.26	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	403.73	100.07	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	457.77	90.71	8.75	1.40	0.54	1.51
Dendritic Cells - plasmacytoid, donor1	11228-116C4	170.48	17.08	0.68	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.68	15.02	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	193.09	11.61	0.97	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	63.21	34.02	1.50	0.33	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	52.81	29.93	1.17	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	73.53	42.70	0.28	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	86.89	41.68	0.79	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	83.19	36.94	1.16	0.29	2.04	0.29
Endothelial Cells - Artery, donor2	11341-117F9	83.05	56.70	0.71	0.24	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	70.30	39.62	1.58	0.35	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	63.84	33.69	0.66	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.90	30.73	0.30	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	44.82	27.34	0.56	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	53.78	37.44	0.59	0.59	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	42.17	21.87	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	60.83	46.08	1.28	0.71	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	61.62	28.81	0.80	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	71.28	44.03	1.57	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	83.25	45.35	0.99	0.37	0.75	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	70.18	53.45	0.00	0.65	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	76.57	48.12	0.73	0.49	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	55.74	34.13	1.14	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	64.26	42.61	2.79	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	65.31	52.44	1.10	0.63	0.79	0.00
Eosinophils, donor1	12244-129H3	60.99	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	453.82	70.96	4.95	3.30	3.30	0.00
Eosinophils, donor3	12246-129H5	420.89	71.34	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	93.09	28.83	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	120.65	14.56	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	96.88	42.28	2.46	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	67.23	19.93	3.72	0.88	0.22	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	113.10	35.21	4.12	1.30	0.22	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	96.90	28.74	2.30	0.24	0.24	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	125.14	20.74	0.55	0.41	0.27	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	136.58	50.20	3.69	1.48	0.32	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	112.77	23.19	2.37	0.79	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	156.47	45.18	1.66	1.00	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	147.43	36.29	2.27	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	116.72	43.20	3.03	0.00	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	71.76	34.54	1.58	0.47	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	91.24	40.01	0.61	1.21	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	71.19	32.87	0.89	0.25	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	98.38	34.41	1.97	0.15	0.91	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	81.47	35.24	1.21	0.00	0.54	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	71.19	37.97	0.86	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	117.18	57.13	1.46	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	227.64	73.11	0.69	0.46	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	221.67	84.97	2.71	0.34	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	141.81	37.10	0.94	0.70	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	107.07	41.98	1.42	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	164.04	50.65	1.93	1.21	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	86.14	41.04	2.15	0.45	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	109.56	41.35	1.57	0.35	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	102.98	51.81	1.62	0.32	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	255.29	54.76	1.46	1.04	1.25	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	198.07	63.93	4.72	1.31	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	212.57	51.79	3.56	1.58	0.92	0.66
Fibroblast - Gingival, donor3	11394-118C8	320.13	76.09	4.83	1.45	0.87	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	86.23	40.52	2.08	0.00	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	112.42	49.87	3.17	1.06	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	202.98	60.80	2.03	0.16	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	188.64	52.20	3.38	0.95	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	302.77	134.45	0.71	0.71	0.71	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	197.58	65.52	1.90	0.29	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	206.98	47.59	3.14	1.23	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	148.74	50.02	1.65	0.44	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	132.06	77.62	3.23	1.47	0.29	1.17
Fibroblast - Lung, donor1	11270-116H1	265.07	62.53	6.80	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	238.74	43.27	2.98	0.00	4.48	1.49
Fibroblast - Lung, donor3	11419-118F6	301.57	72.17	4.22	1.48	2.32	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	343.20	117.46	1.67	0.00	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	153.85	60.14	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	169.04	78.09	1.96	1.12	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	166.04	77.54	0.81	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	135.80	67.90	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	131.04	47.65	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	203.48	49.66	1.75	0.00	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	199.31	58.70	3.34	1.37	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	183.90	37.94	1.53	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	218.67	107.62	1.91	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	158.48	58.86	2.97	0.81	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	114.00	59.73	1.86	0.81	1.16	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	82.24	27.74	0.33	0.11	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	255.61	61.57	2.84	1.22	1.22	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	239.88	57.47	2.67	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	192.54	50.21	0.79	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	145.66	37.31	1.79	0.40	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.68	33.21	0.53	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	105.24	33.70	2.17	0.20	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	131.17	31.59	1.50	0.90	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	121.66	43.94	1.73	0.32	0.11	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	226.00	46.57	1.01	0.51	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	164.08	53.82	1.97	0.66	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	94.84	30.28	0.80	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	117.04	40.79	2.31	0.40	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	197.06	40.50	2.12	0.91	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	112.34	48.38	1.82	0.66	0.66	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	266.51	51.46	3.93	1.03	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	162.57	35.80	1.31	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	137.52	46.44	2.77	0.53	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	110.15	39.47	1.01	0.17	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	65.55	36.07	4.08	1.73	0.63	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	73.21	32.25	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	94.83	27.22	1.04	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	63.76	23.42	1.56	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	94.03	32.19	1.02	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	68.13	27.56	4.59	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.15	25.52	3.19	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	49.92	35.09	2.57	0.57	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.51	38.88	3.31	0.83	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.91	32.88	0.46	0.23	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	63.01	47.35	2.18	0.20	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	25.11	35.16	2.64	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.07	31.96	1.30	0.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	53.95	29.19	0.88	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.43	18.51	0.99	0.71	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.73	16.25	0.74	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.65	22.30	0.81	0.27	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	54.14	23.17	0.99	0.25	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	64.09	22.98	0.97	0.14	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	58.14	23.99	2.64	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	70.05	37.42	3.19	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	67.89	28.90	1.74	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	83.93	47.43	1.09	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	59.39	34.87	1.18	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	54.52	22.73	0.64	0.64	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	68.14	33.96	1.56	0.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	64.72	38.51	2.22	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	52.76	21.21	0.68	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	79.27	31.48	1.60	0.27	0.09	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	112.69	72.21	4.27	0.62	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.22	64.72	3.42	0.17	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	64.29	29.21	0.77	0.33	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.49	28.87	0.83	0.33	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.35	26.54	0.82	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.72	41.26	2.68	0.41	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	60.18	26.63	0.35	0.12	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	72.54	36.35	1.50	0.33	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	86.63	53.56	2.20	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	77.61	33.58	0.86	0.25	0.12	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	56.89	33.39	0.97	0.16	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	91.72	52.28	4.17	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	76.66	34.02	1.71	0.47	0.38	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	84.78	48.40	1.90	0.47	1.11	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	91.23	55.04	4.87	0.61	2.13	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	71.71	29.48	1.25	0.52	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	84.75	46.55	1.76	0.88	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	90.06	41.24	2.24	0.28	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	90.55	36.48	2.59	0.74	0.46	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	89.05	52.95	1.07	1.07	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	95.17	49.42	1.07	0.31	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	80.05	31.35	0.91	0.26	0.78	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	88.91	56.65	1.63	0.27	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	78.90	40.74	0.92	0.92	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	75.00	49.35	1.54	0.22	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	89.26	65.46	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	84.29	44.72	0.53	1.19	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	81.51	47.01	1.82	0.40	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	84.13	61.00	1.27	0.51	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	71.86	19.91	1.00	0.40	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	53.93	18.03	0.92	0.15	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	70.99	20.05	0.20	0.20	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.22	16.59	0.94	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.69	10.74	1.13	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	32.75	15.68	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	24.75	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	33.65	14.70	1.16	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	14.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	15.65	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.55	14.65	0.65	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	34.59	21.83	0.82	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	23.33	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	39.15	15.94	0.56	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	40.53	20.59	0.98	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	30.20	22.65	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	40.40	22.27	0.64	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.08	19.36	0.34	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	22.97	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	50.40	26.92	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	47.65	25.16	0.89	0.59	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	10.16	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.88	22.37	1.24	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.00	15.88	0.46	0.00	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	15.81	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	14.99	0.38	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	47.27	20.86	1.30	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	32.77	0.67	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	54.71	40.84	2.70	0.39	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	49.30	22.59	1.37	1.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	32.30	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	37.75	25.01	0.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.87	37.42	1.21	2.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	43.24	31.54	2.54	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.46	31.11	1.20	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	36.01	21.71	1.48	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	9.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	31.51	23.34	0.58	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.74	22.82	0.44	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	42.38	17.80	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	36.41	19.10	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	42.22	17.95	0.49	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	94.73	36.52	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	196.27	62.37	4.99	1.25	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	194.53	66.34	7.87	3.37	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	155.41	54.87	1.59	0.32	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	168.77	40.94	2.51	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	89.12	28.08	1.39	0.23	0.70	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	99.76	28.87	1.18	0.17	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	87.36	34.13	1.59	1.14	1.14	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	91.05	30.17	1.53	0.33	1.31	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	93.06	31.81	1.07	0.21	1.93	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	81.81	27.13	1.08	0.86	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	91.78	33.38	1.25	0.25	0.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	82.69	25.05	1.37	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	79.13	23.39	0.32	0.32	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	94.58	71.63	1.12	1.12	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	102.14	61.02	3.90	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	31.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	177.77	61.73	1.06	0.35	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	135.86	58.12	2.18	2.91	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	77.10	25.70	1.57	0.35	0.17	0.00
Hepatocyte, donor1	11523-119I2	79.90	7.26	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	93.73	7.54	2.15	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	56.45	14.11	3.07	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	75.06	21.54	1.96	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	131.61	17.30	1.75	0.70	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	118.82	44.45	0.96	0.14	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	89.15	152.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	86.78	106.80	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	216.67	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	92.75	121.83	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	97.60	167.68	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	130.55	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	79.45	138.40	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	123.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	95.84	149.44	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	86.70	133.38	1.67	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	119.81	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	116.47	158.82	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	84.26	110.86	0.00	1.11	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	115.24	104.77	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	78.10	79.36	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	95.89	116.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	58.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	85.92	111.76	3.88	0.65	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	115.91	157.77	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	107.53	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	103.49	132.01	3.26	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	95.72	146.93	1.26	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	129.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	100.46	94.83	2.41	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	66.48	108.95	0.92	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	90.48	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	83.08	96.77	1.89	0.94	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	74.37	104.30	0.91	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	73.71	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	103.31	105.46	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	111.80	155.00	3.81	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	82.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	123.07	117.33	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	85.67	118.47	5.47	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	63.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	103.54	120.68	1.43	0.00	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	112.82	142.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	166.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.29	81.79	2.47	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	79.02	121.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	84.86	81.72	0.00	0.00	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	102.92	98.05	2.09	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	132.79	188.11	11.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	139.41	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	117.71	149.97	3.49	0.87	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	96.74	182.23	4.50	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	94.08	160.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	122.68	128.01	2.13	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	90.05	138.54	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	79.79	96.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	92.96	103.09	7.36	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	139.16	248.08	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	117.96	167.63	0.00	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	119.48	150.15	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	59.57	20.07	0.82	0.33	0.00	0.33
Keratinocyte - epidermal, donor2	11349-117G8	49.19	23.43	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	62.28	22.24	0.76	0.76	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	55.17	31.56	0.45	0.11	0.00	0.11
Keratocytes, donor1	11527-119I6	157.47	22.35	0.34	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	214.44	75.00	2.34	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	143.85	23.12	1.19	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	195.61	43.96	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	165.05	31.28	2.16	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	72.77	50.28	0.81	0.12	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	120.79	46.52	0.61	0.40	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.28	33.20	0.59	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.09	27.35	0.84	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.84	23.14	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	32.80	21.51	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	31.20	33.41	0.32	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	35.58	23.61	0.75	0.11	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.09	24.21	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.11	39.69	1.52	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.05	26.88	0.56	0.56	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	22.55	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.86	25.20	0.00	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	41.84	29.25	0.19	0.37	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	24.39	0.00	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.35	27.19	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	34.89	27.47	0.41	0.55	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	36.65	22.17	0.31	0.92	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.93	30.55	0.62	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	37.88	32.94	0.91	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	27.65	27.32	0.00	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.61	32.22	0.29	1.17	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.82	28.63	0.75	0.50	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.70	29.10	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.04	27.20	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	33.76	28.61	1.21	0.45	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.92	24.88	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.76	28.90	0.42	0.00	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	36.99	31.28	0.60	0.30	0.75	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	23.39	27.52	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.59	29.54	0.38	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	41.35	28.31	1.27	0.32	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.47	24.71	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	30.43	25.14	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	35.68	32.96	0.50	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.98	31.47	1.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	29.16	24.96	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	34.24	31.76	1.10	0.27	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.98	19.94	0.64	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	26.78	28.91	0.30	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.27	29.53	0.56	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.02	23.47	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	28.12	31.51	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	34.54	30.19	1.09	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	30.80	27.57	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.67	28.42	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	40.02	24.25	0.47	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.57	28.83	0.50	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.50	33.04	0.26	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	31.92	23.57	1.79	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	15.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	63.67	26.08	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	63.09	20.78	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	68.97	26.23	1.27	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	66.82	23.21	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	48.57	16.81	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	55.13	26.79	4.64	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	71.37	29.74	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	65.14	27.14	0.68	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	56.71	25.30	2.04	1.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	62.12	25.21	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	71.13	27.10	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	70.35	30.30	3.08	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	57.16	23.29	1.41	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.31	19.99	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.67	27.51	1.53	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	59.50	21.08	1.60	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	60.84	27.21	1.13	0.76	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	61.36	30.68	1.23	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	73.39	38.32	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.52	20.62	1.67	0.21	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	55.77	20.18	0.28	0.84	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	71.09	25.76	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	62.13	24.68	3.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	52.61	26.31	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	51.45	21.58	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	72.11	36.06	4.60	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	68.96	25.08	2.58	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	77.14	23.03	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	60.63	28.01	1.15	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	57.75	23.21	3.40	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	21.33	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	72.30	28.02	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	68.22	23.70	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.18	30.62	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	74.69	23.41	3.34	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.86	21.11	1.29	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	65.93	29.11	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	77.30	23.66	2.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	83.26	31.98	1.21	0.60	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.72	27.02	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	65.99	28.53	3.09	0.34	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	67.63	24.69	1.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	80.80	39.05	2.02	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	59.27	30.37	2.22	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	60.47	22.10	1.16	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	70.87	14.81	0.00	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	70.83	31.61	2.40	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	66.87	26.89	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	67.45	14.56	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	59.19	27.13	2.96	0.49	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	62.10	31.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	77.94	27.66	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	67.14	22.98	2.70	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	30.98	5.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	77.94	28.95	3.12	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	64.52	30.11	3.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	25.73	1.32	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	60.71	31.14	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	72.64	28.44	3.94	1.31	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	71.01	22.92	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	63.15	25.17	2.21	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	61.33	26.23	1.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	71.40	19.24	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.96	22.11	0.00	0.48	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	73.15	32.20	0.80	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	66.23	32.20	3.65	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	54.64	15.22	2.08	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	83.22	28.50	2.66	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	53.19	28.92	1.55	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	67.12	21.16	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	61.16	22.82	3.17	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	62.37	25.59	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	54.02	14.94	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	71.99	29.31	1.03	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	68.61	19.10	0.71	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	68.10	21.00	0.57	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	71.97	25.38	3.33	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	70.47	32.10	2.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	68.90	15.45	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	70.16	29.27	2.79	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	66.24	18.06	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.73	18.18	1.07	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	70.31	27.48	3.23	0.81	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	74.34	30.29	0.92	2.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	87.13	34.68	2.67	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	76.36	24.50	3.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	65.19	30.68	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	75.51	18.06	2.19	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	72.16	29.84	2.23	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	67.07	22.88	1.04	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	84.21	19.89	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	31.18	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	129.68	71.34	0.68	0.68	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	317.47	89.18	4.04	1.47	0.37	0.73
Macrophage - monocyte derived, donor3	11389-118C3	223.36	92.54	4.06	1.44	0.26	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	48.32	18.59	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	62.91	21.71	1.11	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	59.76	22.65	0.69	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	43.25	19.53	0.10	0.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	52.12	20.56	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	51.13	26.19	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	47.46	25.08	5.42	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	294.58	128.80	4.33	3.89	0.97	1.51
Mast cell, donor2	11565-120D8	512.03	174.44	15.75	11.89	2.67	7.43
Mast cell, donor3	11566-120D9	510.58	215.89	13.73	11.71	3.38	5.85
Mast cell, donor4	11567-120E1	562.01	177.82	21.98	15.25	0.53	11.52
Mast cell, expanded and stimulated, donor5	11940-126A5	290.76	97.81	5.43	1.55	6.10	2.00
Mast cell, expanded and stimulated, donor8	11942-126A7	182.11	76.46	6.42	5.25	29.18	2.92
Mast cell, expanded, donor5	11939-126A4	354.49	140.76	10.78	7.23	0.69	3.44
Mast cell, expanded, donor8	11941-126A6	372.22	163.35	16.57	10.54	4.35	5.19
Melanocyte - dark, donor1	11502-119F8	35.92	29.35	0.20	0.20	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	96.56	45.34	1.38	0.00	1.73	0.00
Melanocyte - dark, donor3	11663-122F7	78.89	36.44	0.22	0.07	0.22	0.07
Melanocyte - light, donor1	11274-116H5	135.40	67.23	3.53	0.94	0.47	0.47
Melanocyte - light, donor2	11351-117H1	144.68	60.74	7.51	3.41	1.36	6.14
Melanocyte - light, donor3	11423-118G1	111.00	41.63	1.73	1.73	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	92.36	27.80	1.25	0.42	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	62.66	27.43	0.00	0.54	1.61	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	78.48	39.37	1.07	0.80	0.27	0.27
Meningeal Cells, donor1	11493-119E8	257.18	58.06	1.36	0.37	0.50	0.12
Meningeal Cells, donor2	11573-120E7	364.00	78.35	5.28	1.76	3.96	0.44
Meningeal Cells, donor3	11654-122E7	177.35	49.06	1.22	0.33	0.49	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	120.62	52.47	1.14	0.29	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	58.57	29.59	0.70	0.10	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	233.92	109.08	5.26	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	276.02	90.26	0.00	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	86.11	35.16	2.15	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	99.74	33.46	2.33	0.64	0.42	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	130.19	51.77	4.02	2.01	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	104.82	49.66	0.44	0.00	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	82.56	40.18	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	85.52	38.26	1.43	0.41	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	107.07	43.91	0.69	0.14	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	135.68	43.49	1.49	0.00	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	75.00	33.42	0.13	0.13	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	64.69	40.06	0.30	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	67.73	44.38	2.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	109.51	42.91	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	81.88	42.53	0.35	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	59.73	30.33	0.63	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	65.31	24.67	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	145.32	36.59	1.33	0.80	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	127.62	23.02	0.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	185.21	47.62	3.69	0.94	0.72	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	368.64	156.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	300.45	102.45	1.23	1.23	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	416.36	132.80	3.83	0.88	0.29	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	518.56	145.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	192.17	71.29	3.72	0.62	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	337.70	103.92	3.11	1.87	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	333.51	99.59	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	253.52	88.84	4.50	1.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	424.52	146.63	0.47	0.93	0.93	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	428.26	253.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	272.92	84.94	1.83	1.22	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	349.24	97.01	1.98	0.40	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	384.82	145.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	208.85	66.37	5.31	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	352.58	113.98	5.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	282.92	96.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	202.89	71.31	3.61	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	355.44	105.89	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	215.49	76.00	2.09	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	373.90	142.52	0.00	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	305.54	169.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	181.65	57.71	4.27	0.75	0.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	278.78	81.76	2.61	0.48	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	152.60	63.58	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	166.24	56.41	4.14	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	276.60	90.24	2.52	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	193.03	69.91	1.43	1.63	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	158.12	52.78	3.00	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	288.31	89.81	0.67	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	237.33	154.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	125.50	43.37	1.10	0.44	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	307.22	107.98	0.00	1.52	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	207.12	61.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	164.43	53.27	1.63	0.27	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	271.73	96.17	0.88	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	207.16	75.23	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	157.14	44.21	0.48	0.48	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	227.33	80.05	2.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	270.13	94.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	190.22	52.56	2.00	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	188.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	209.97	65.23	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	161.59	46.42	1.31	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	328.89	97.12	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	239.51	92.22	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	164.62	45.62	2.23	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	276.27	100.90	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	238.67	148.06	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	135.72	50.94	4.44	1.37	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	304.14	101.53	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	193.53	72.79	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	144.76	57.51	2.81	1.12	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	227.35	85.62	0.42	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	201.63	107.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	165.01	53.39	2.41	1.21	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	218.71	66.37	4.59	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	238.22	180.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	120.99	58.18	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	346.59	111.55	2.85	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	146.75	69.23	0.69	0.97	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	122.58	52.35	3.11	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	304.14	110.25	2.14	2.14	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	154.99	126.40	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	112.63	51.78	0.53	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	215.22	82.02	2.99	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	96.19	49.02	0.42	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	109.89	49.37	1.91	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	251.43	108.35	0.44	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	140.68	95.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	100.57	51.42	1.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	228.84	91.44	5.16	0.98	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	110.13	87.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	84.97	59.39	2.35	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	181.07	73.81	3.46	0.86	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	121.99	74.60	0.41	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	88.44	61.05	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	33.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	98.02	55.25	1.78	3.56	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	95.29	79.19	2.96	0.33	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	149.38	74.69	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	126.32	69.78	1.19	0.20	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	335.28	120.14	3.73	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	196.03	69.47	3.38	0.75	0.38	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	264.48	89.49	2.40	0.80	0.27	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	65.71	40.83	0.90	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	152.50	75.88	0.00	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	95.27	61.93	3.30	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	155.56	77.78	3.11	4.67	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	58.25	31.00	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	127.51	42.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	123.21	65.65	6.06	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	153.06	62.82	2.95	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	17.71	1.36	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	54.68	7.63	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	26.72	7.29	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	45.31	34.74	0.00	0.00	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	17.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	140.29	19.57	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	133.07	38.02	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	161.58	32.53	1.51	0.00	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	133.79	45.99	2.09	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	69.42	53.40	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	82.22	59.68	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	48.68	43.16	1.52	0.76	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	157.99	105.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	50.32	48.96	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	53.29	22.05	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	100.03	60.27	1.26	1.26	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	90.42	48.35	0.23	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	158.62	87.28	3.24	1.35	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	125.93	59.50	1.89	0.63	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	113.17	55.59	1.49	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	48.45	34.10	1.35	1.08	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	119.23	52.36	1.81	0.45	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	147.95	78.87	0.82	0.33	0.33	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	98.60	49.39	1.64	0.73	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	98.13	48.80	2.12	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	105.05	57.03	3.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.38	40.37	2.95	1.64	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	116.28	50.58	1.63	0.16	0.49	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	109.53	61.56	0.35	0.35	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	71.73	30.94	1.41	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	87.80	56.08	1.38	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	69.09	34.71	2.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	55.87	31.38	2.07	1.72	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	111.25	50.57	0.00	10.11	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	77.97	43.67	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	71.13	42.34	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	62.90	38.21	2.37	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	61.38	34.77	0.00	0.86	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	90.64	53.65	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.98	43.28	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.08	22.22	1.59	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	85.44	41.79	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	34.43	28.00	1.14	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	72.02	33.24	2.28	0.33	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	112.00	58.83	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	53.37	43.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	20.28	0.88	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	84.44	37.23	3.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	64.49	52.08	1.49	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	63.55	41.73	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	53.53	31.15	2.12	1.21	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	59.23	34.04	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	41.34	27.11	0.68	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	20.44	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	59.14	29.87	0.00	1.22	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	51.93	39.03	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	85.95	78.39	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	38.77	26.11	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	24.94	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	60.87	20.13	1.24	0.50	0.12	0.00
Myoblast, donor2	11322-117D8	84.39	39.51	2.49	0.58	0.19	0.00
Myoblast, donor3	11398-118D3	38.00	21.69	0.67	0.17	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	35.17	23.20	0.00	0.29	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	170.06	25.22	0.92	1.23	1.85	0.62
Natural Killer Cells, donor2	11311-117C6	142.33	25.63	1.51	2.41	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	147.61	28.90	1.84	0.74	1.10	0.37
Neural stem cells, donor1	11275-116H6	15.61	25.77	0.36	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	15.41	25.03	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	0.00	9.10	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	11.45	10.79	0.00	0.00	0.00	0.00
Neurons, donor3	11655-122E8	1.64	5.76	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	620.84	83.52	15.78	1.86	3.71	0.00
Neutrophils, donor2	11314-117C9	571.08	98.56	28.99	17.39	5.80	0.00
Neutrophils, donor3	11390-118C4	689.64	128.28	15.27	3.67	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	258.84	89.17	3.09	1.31	0.36	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	341.88	93.77	2.93	1.30	1.30	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	176.49	42.92	1.20	0.60	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	137.51	58.91	0.83	0.28	0.14	0.55
Olfactory epithelial cells, donor2	11934-125I8	102.33	47.33	2.89	1.45	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	80.59	40.86	1.48	0.68	0.34	0.11
Olfactory epithelial cells, donor4	11936-126A1	136.06	63.41	1.07	0.19	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	177.54	37.31	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	75.29	40.62	2.34	1.06	0.00	1.28
Osteoblast - differentiated, donor2	11353-117H3	78.87	45.72	6.86	3.43	0.00	5.72
Osteoblast - differentiated, donor3	11425-118G3	94.35	31.66	1.86	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	77.00	46.90	0.59	0.59	0.39	0.39
Osteoblast, donor2	11354-117H4	58.29	27.39	0.70	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	73.05	37.86	1.42	0.18	0.53	0.53
Pancreatic stromal cells, donor1	11249-116E7	163.42	35.80	3.20	0.67	0.34	0.67
Pericytes, donor1	11491-119E6	293.41	75.66	2.45	0.45	0.56	0.33
Pericytes, donor2	11571-120E5	201.01	70.63	2.26	1.58	0.68	0.45
Pericytes, donor3	11652-122E5	159.30	50.05	2.24	1.83	0.61	0.61
Perineurial Cells, donor1	11499-119F5	92.00	34.02	0.45	0.45	0.34	0.23
Perineurial Cells, donor2	11579-120F4	106.00	48.12	0.92	0.37	1.01	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	162.56	48.77	2.87	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	147.90	56.56	2.69	2.20	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	130.19	44.39	1.55	0.52	0.91	0.26
Placental Epithelial Cells, donor1	11278-116H9	80.12	27.03	2.87	1.20	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	149.70	48.79	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	107.78	50.06	1.37	0.20	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	76.90	38.29	4.75	1.27	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	92.48	25.32	2.63	0.56	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	124.91	30.41	0.78	0.13	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	126.31	46.61	3.60	0.90	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	112.85	33.25	3.30	0.64	0.64	0.85
Preadipocyte - omental, donor2	11329-117E6	132.25	37.54	1.75	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	115.74	47.27	2.44	0.86	1.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	131.89	26.58	2.95	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	97.05	39.93	0.61	0.00	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	106.60	57.02	1.59	0.18	0.89	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	88.21	47.00	2.72	0.85	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	115.78	51.51	2.14	0.37	0.19	0.37
Preadipocyte - visceral, donor2	11357-117H7	98.02	64.89	4.60	0.00	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	111.91	41.59	2.72	0.84	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	135.01	12.67	3.02	1.36	0.00	1.06
Prostate Epithelial Cells, donor2	11331-117E8	82.47	20.18	3.25	0.41	0.00	0.95
Prostate Epithelial Cells, donor3	11404-118D9	79.91	11.94	1.47	0.61	0.06	0.24
Prostate Stromal Cells, donor1	11254-116F3	119.94	37.02	1.59	0.46	0.80	0.34
Prostate Stromal Cells, donor2	11332-117E9	171.05	54.15	5.74	1.08	0.54	0.72
Prostate Stromal Cells, donor3	11405-118E1	160.38	64.34	4.17	1.36	0.63	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	292.35	66.79	1.46	1.46	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	147.50	48.52	1.66	0.62	0.14	0.49
Renal Epithelial Cells, donor1	11517-119H5	217.09	92.32	2.03	0.51	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	181.39	74.69	0.71	0.00	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	117.19	49.65	0.95	0.32	0.00	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	102.81	77.62	2.04	0.68	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	108.22	48.65	1.62	0.13	1.21	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	73.49	40.63	1.78	0.44	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	79.85	71.87	0.67	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	133.81	54.80	1.32	0.22	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	153.61	73.98	2.51	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	181.43	86.83	3.05	1.39	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	322.64	62.81	1.34	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	260.61	56.09	5.48	2.11	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	173.76	79.45	2.89	0.96	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	162.05	50.30	1.04	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	199.82	54.86	0.85	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	167.75	46.31	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	102.62	25.59	1.00	0.75	0.25	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	146.06	35.15	3.34	0.13	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	59.86	33.95	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.26	16.51	3.85	0.55	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	17.40	1.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	59.42	22.10	0.39	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	59.38	39.03	0.70	0.20	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	59.34	32.46	0.45	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	58.42	28.41	0.25	0.50	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	66.55	38.23	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	76.04	36.75	1.16	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	56.54	26.15	0.41	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	61.72	38.42	1.36	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	52.50	29.21	0.36	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.27	30.70	0.86	0.14	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	62.99	36.38	1.29	0.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.64	34.08	0.66	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.50	24.28	0.76	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	60.46	35.77	0.84	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.62	39.27	0.94	0.75	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	64.63	31.05	0.40	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	67.36	40.10	1.36	0.19	0.19	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.16	38.38	0.95	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	65.25	29.80	0.64	0.32	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	67.55	37.00	0.56	0.84	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.28	35.03	0.51	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	69.10	28.08	0.18	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	58.62	40.10	0.98	0.98	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.95	37.07	0.67	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	66.99	26.18	1.42	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	60.12	34.52	1.39	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	69.22	41.86	1.40	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.89	23.64	0.83	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.58	41.59	1.11	1.11	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	58.91	31.54	1.04	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	60.97	27.99	1.35	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	69.14	42.40	0.34	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.34	35.09	0.19	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	55.54	23.38	1.20	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	60.49	37.45	0.14	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.33	29.88	0.66	0.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	61.53	27.10	0.85	0.00	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	58.15	44.54	0.59	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.57	33.59	0.80	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	58.90	30.28	0.55	0.55	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.57	31.19	0.95	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	73.36	48.57	1.01	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	55.00	23.83	1.70	0.47	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	78.61	41.22	1.75	0.70	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	59.54	28.71	0.91	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	67.44	28.88	1.96	0.37	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	62.15	24.16	1.31	0.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.06	31.03	1.22	0.00	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.25	30.44	0.90	0.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	87.08	34.83	5.88	1.36	0.00	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	84.17	29.65	2.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	66.12	24.44	4.60	1.06	0.12	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	83.03	30.31	7.68	1.49	0.00	5.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	80.53	31.85	6.01	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	285.87	92.72	3.57	0.94	1.13	0.00
Schwann Cells, donor2	11578-120F3	122.49	34.02	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	108.66	50.83	1.53	0.66	0.44	0.22
Sebocyte, donor1	11220-116B5	80.52	35.06	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	69.39	23.90	1.84	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	90.28	48.64	2.47	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	160.69	34.79	1.66	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	152.52	45.19	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	73.37	35.98	0.88	0.44	0.62	0.44
Skeletal Muscle Cells, donor2	11358-117H8	42.65	36.14	0.72	0.00	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	163.86	61.87	2.51	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	122.38	44.93	1.89	0.47	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	100.63	42.22	1.64	0.45	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	90.49	39.55	1.08	0.46	0.00	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	122.10	69.30	1.39	0.63	0.50	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	143.97	60.79	3.42	1.00	0.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	113.10	46.63	2.08	0.50	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	68.75	41.28	0.67	0.17	0.08	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	99.16	47.77	2.90	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	92.88	33.85	3.30	1.51	0.96	0.00
Skin - palm, donor1	10286-104F7	169.22	40.29	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	54.35	17.01	1.59	0.14	0.00	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	19.63	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	66.08	24.28	1.69	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	73.12	20.99	2.22	0.56	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	92.69	30.66	1.13	0.28	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.77	21.36	0.21	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	67.83	14.84	0.60	0.30	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	126.83	47.52	1.23	0.62	2.16	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	101.16	22.68	2.22	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	106.40	49.97	1.76	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	95.03	26.30	0.66	0.44	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	157.51	40.95	1.58	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	130.56	54.85	0.77	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	82.06	79.06	1.00	1.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	140.66	40.99	2.53	0.53	1.20	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	126.12	39.45	1.77	0.89	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	94.23	18.05	2.18	0.13	0.64	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	113.63	34.19	0.33	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	98.34	30.42	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	125.00	37.87	1.42	0.28	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	204.64	49.78	1.14	0.33	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	268.51	36.53	1.83	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	139.16	63.90	2.53	1.01	1.26	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	24.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	205.99	61.04	3.81	0.00	1.91	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	84.65	35.25	0.44	0.15	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	93.84	32.93	1.72	0.22	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	89.84	32.64	1.78	0.10	0.42	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	160.25	45.17	1.39	0.46	1.08	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	189.71	38.80	4.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	124.03	40.35	0.90	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	179.58	71.69	1.02	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	108.29	57.88	0.94	0.47	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	152.07	44.79	5.54	2.62	0.50	1.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	139.26	34.59	1.37	0.68	1.82	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	192.01	49.51	2.42	1.21	6.04	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	111.00	40.80	0.53	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	161.79	51.93	2.26	0.67	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	144.50	67.87	4.51	1.38	0.88	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	179.85	58.60	3.04	2.28	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	225.56	58.95	2.86	1.51	1.51	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	178.54	57.01	2.25	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	33.60	1.29	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	158.12	56.74	2.33	2.33	3.72	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	232.75	41.40	3.03	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	201.51	31.34	6.89	2.19	1.57	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	167.26	49.26	0.88	0.88	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	128.13	42.90	0.75	0.33	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	311.60	77.08	2.80	2.80	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	152.70	40.01	1.73	0.86	1.73	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	146.09	53.54	1.78	1.27	0.76	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	126.55	45.50	2.26	1.32	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	74.76	40.25	0.28	0.00	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	79.93	41.48	0.34	0.25	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	51.43	37.62	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	172.24	45.51	2.45	0.98	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	106.28	46.18	0.44	0.66	0.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	112.06	45.35	1.76	0.88	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	106.12	35.76	2.92	0.58	0.00	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	100.49	24.59	2.91	0.53	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	58.77	24.55	10.04	0.74	0.37	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	156.31	36.65	3.23	1.44	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	103.91	17.60	1.99	0.00	1.42	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	86.26	31.12	0.39	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	91.93	29.71	4.57	1.02	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	152.14	53.51	4.39	2.00	1.20	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	163.02	33.44	3.34	1.67	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	165.01	29.34	2.29	0.46	0.46	0.46
Synoviocyte, donor1	11291-117A4	95.44	36.86	1.68	0.50	0.50	0.84
Synoviocyte, donor2	11368-117I9	178.02	34.87	4.19	1.84	2.51	0.84
Synoviocyte, donor3	11440-118H9	154.38	28.37	5.14	0.67	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	277.65	102.20	0.36	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	138.74	55.50	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	244.98	82.66	1.39	0.69	1.39	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	55.63	18.57	0.65	0.43	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	97.80	36.72	1.55	0.77	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	102.51	29.78	2.86	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	146.64	32.36	4.31	0.49	0.12	0.62
Urethra, donor2	10319-105A4	267.97	82.73	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	86.34	28.43	1.06	0.00	0.00	0.53
Urothelial Cells, donor2	11600-120H7	69.70	25.24	1.20	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	88.01	30.71	1.15	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	56.39	31.21	0.45	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	373.71	66.73	3.56	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	396.00	77.20	2.86	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	285.44	56.82	2.74	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	220.38	51.65	1.72	0.34	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	256.81	59.85	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	375.89	40.61	4.16	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	324.90	37.63	1.84	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	249.22	52.04	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	60.20	42.56	0.12	0.25	0.00	0.37
Wilms' tumor cell line:HFWT	10597-108E3	70.40	29.04	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	376.80	80.44	2.23	1.12	0.28	0.56
achilles tendon, donor2	10292-104G4	171.52	37.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	100.96	26.26	0.51	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.88	15.56	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	110.28	36.56	0.95	0.00	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	81.91	36.46	0.82	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	139.42	53.69	2.53	1.41	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	130.48	157.13	1.69	0.63	2.33	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	111.88	71.59	2.72	1.09	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	103.99	91.21	0.88	1.76	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	243.79	159.67	5.72	1.63	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	100.96	61.74	1.16	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	97.70	55.20	2.21	0.37	0.74	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	132.62	89.71	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	100.16	89.23	1.63	0.46	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.67	48.41	0.78	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	55.53	60.49	2.34	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.28	80.40	0.93	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	119.26	67.86	1.23	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	86.87	99.14	0.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	89.61	67.42	0.85	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	96.45	70.97	0.61	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	104.47	78.95	0.24	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	95.78	37.42	0.89	0.45	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	80.72	48.03	1.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	46.46	63.18	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	96.80	69.31	1.88	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.01	112.96	0.00	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	63.73	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	186.52	21.67	1.18	0.47	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	228.18	57.55	4.81	0.93	0.62	0.78
adipose, donor1	10184-103D4	3.52	5.86	3.52	0.00	0.00	0.00
adipose, donor2	10185-103D5	28.39	41.77	1.22	0.41	0.00	0.41
adipose, donor3	10186-103D6	29.95	29.13	0.82	0.27	0.00	0.27
adipose, donor4	10187-103D7	29.47	25.14	0.00	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	72.12	143.93	0.95	0.63	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	43.65	14.55	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	175.96	51.76	1.47	0.27	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	133.27	53.24	1.43	0.71	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	139.34	30.84	0.93	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	98.73	30.77	2.37	1.35	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	132.28	33.29	1.47	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	54.55	30.83	1.19	3.56	1.19	0.00
amygdala, adult, donor10252	10151-102I7	82.93	42.38	1.22	0.41	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	22.27	17.75	0.32	0.65	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	58.83	31.32	0.38	0.38	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	125.76	40.37	1.32	0.44	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	119.25	71.15	0.33	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	196.53	62.96	2.16	1.18	0.00	0.39
appendix, adult	10189-103D9	207.26	50.46	3.10	1.55	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	26.83	31.99	0.34	0.00	0.00	0.00
artery, adult	10190-103E1	205.16	38.04	9.51	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	35.35	25.21	0.14	0.14	0.14	0.00
b cell line:RPMI1788	10427-106D4	98.14	81.93	1.34	0.45	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	145.66	44.39	1.94	0.00	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	180.11	41.98	1.29	0.10	1.09	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	116.83	6.86	0.33	0.00	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.21	67.67	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	176.00	53.45	4.13	0.76	0.22	0.43
blood, adult, pool1	10053-101G8	150.59	55.37	0.00	2.21	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.88	51.38	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	84.35	45.21	1.35	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	47.15	34.85	3.08	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	84.52	37.42	1.78	0.78	0.11	0.00
brain, fetal, pool1	10085-102B4	5.34	21.37	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	87.55	37.66	0.66	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	6.99	3.37	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	276.53	49.25	3.16	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	184.08	35.82	1.91	0.51	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	64.63	29.07	1.24	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.86	52.26	2.30	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	67.30	26.87	0.48	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	13.63	6.11	0.47	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	77.55	16.41	0.33	0.11	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	30.11	18.06	0.00	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.71	16.77	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	49.51	27.63	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	79.81	30.79	1.17	0.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	89.40	38.97	0.76	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	39.92	13.18	1.46	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	46.61	26.22	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	91.60	39.93	1.71	0.21	0.21	0.21
cerebellum, adult, pool1	10083-102B2	47.95	24.49	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	14.95	9.13	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	76.40	34.29	2.77	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	80.40	32.16	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	60.53	37.53	0.72	0.43	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	422.08	39.94	3.15	0.66	0.00	0.33
cervix, adult, pool1	10013-101C4	171.45	59.00	5.14	1.26	0.31	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.63	11.43	0.28	0.14	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	48.33	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	82.64	48.22	1.99	0.75	0.00	0.87
choriocarcinoma cell line:SCH	10785-110H2	91.18	43.49	0.62	0.25	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	55.50	47.44	0.24	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	105.14	37.32	0.85	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	124.89	34.20	4.28	1.09	0.40	1.19
chorionic membrane cells, donor3	12240-129G8	169.79	56.05	4.40	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	114.11	6.06	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	66.27	55.32	0.58	0.58	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.55	58.50	0.42	0.42	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	54.18	97.33	0.77	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	61.44	98.69	1.94	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.29	93.25	1.02	0.61	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	47.70	77.74	0.00	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	50.04	40.92	0.26	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.66	66.52	2.51	0.46	0.00	0.69
clear cell carcinoma cell line:TEN	10636-108I6	172.81	36.96	1.91	0.52	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	151.74	40.64	0.55	0.37	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	42.19	41.05	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	202.31	35.70	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	240.06	34.66	5.99	3.41	0.24	1.88
colon, fetal, donor1	10070-101I7	135.34	42.64	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	155.84	201.67	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	50.14	28.05	1.27	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	75.92	40.45	1.06	0.75	0.75	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	89.68	49.92	0.56	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	58.71	32.73	0.55	0.00	0.00	0.00
cruciate ligament, donor2	10295-104G7	178.30	44.58	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	107.54	33.71	1.61	0.80	0.00	0.80
diencephalon, adult	10193-103E4	52.56	21.84	0.72	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	69.57	26.18	1.38	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	122.83	43.34	0.51	0.51	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	57.29	36.35	0.72	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	101.16	39.37	1.99	1.50	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	155.54	40.33	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	149.34	36.05	4.41	2.21	0.00	1.47
dura mater, adult, donor1	10041-101F5	193.58	64.17	1.65	0.99	0.50	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.08	12.66	1.33	0.89	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	76.23	22.93	1.43	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	291.66	112.22	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	240.05	155.29	1.51	0.91	0.00	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	213.65	83.05	1.23	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	245.62	90.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	55.98	21.45	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	49.30	68.14	0.18	0.00	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	327.09	68.67	7.08	2.09	0.80	1.61
epidermoid carcinoma cell line:A431	10426-106D3	228.43	22.90	1.00	0.44	0.33	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	198.63	39.92	1.10	0.33	0.33	0.22
epididymis, adult	10197-103E8	216.22	53.16	7.95	4.60	0.42	3.77
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	97.40	43.64	0.71	0.35	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	53.87	22.02	0.79	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	118.47	29.75	2.23	0.00	0.00	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	114.17	28.34	1.18	0.39	0.49	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	132.08	29.58	2.24	0.67	0.45	0.34
esophagus, adult, pool1	10015-101C6	276.91	40.35	5.84	2.23	0.42	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.90	30.06	0.13	0.13	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	234.21	45.88	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	210.42	35.77	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	220.26	46.13	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	174.27	51.59	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	39.35	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	101.69	29.49	1.02	0.51	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	58.47	41.67	0.64	0.51	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	58.64	36.56	0.47	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	86.22	39.03	0.28	0.19	0.09	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	217.68	11.11	1.20	0.90	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	98.57	29.44	0.27	0.00	0.37	0.00
gall bladder, adult	10198-103E9	274.27	59.15	5.31	2.41	0.48	1.45
gamma delta positive T cells, donor1	11937-126A2	172.87	39.19	1.61	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	166.58	31.37	2.99	0.00	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.54	8.87	1.27	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	126.49	14.31	0.19	0.19	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	50.66	81.81	0.98	0.33	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	65.90	73.22	2.75	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	38.84	19.19	0.91	0.46	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	43.83	8.03	0.11	0.11	0.46	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	93.91	56.96	0.28	0.14	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	172.85	34.67	0.00	1.00	1.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	108.82	39.37	0.63	0.11	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	105.05	41.01	0.56	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	84.99	27.59	0.88	0.11	0.11	0.11
glioma cell line:GI-1	10413-106B8	58.87	37.78	1.76	0.59	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	37.90	16.04	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	54.92	25.87	0.49	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	23.28	15.06	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.32	10.13	0.53	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	271.63	217.80	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	54.64	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	26.13	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.28	27.84	0.32	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	56.47	21.58	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	65.39	22.41	1.83	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	49.60	13.53	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	27.31	12.94	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	43.90	10.97	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	47.45	15.45	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	141.37	93.10	2.59	0.57	0.57	0.57
heart - mitral valve, adult	10205-103F7	210.47	44.25	2.69	0.60	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	270.89	50.20	2.35	1.31	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	148.21	24.15	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	229.77	53.46	3.26	1.02	0.82	0.82
heart, adult, diseased, donor1	10051-101G6	343.22	51.10	5.96	3.41	1.28	0.43
heart, adult, pool1	10016-101C7	343.13	45.08	6.21	1.38	0.92	0.23
heart, fetal, pool1	10046-101G1	223.23	55.76	1.44	0.31	0.82	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	77.44	46.59	0.62	0.31	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	77.30	36.86	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	51.38	32.71	0.77	0.00	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.86	33.01	0.61	0.24	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	53.86	34.46	0.51	0.00	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	51.83	9.68	0.44	0.11	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	39.80	30.55	0.20	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	57.73	24.60	0.00	0.00	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	71.03	34.70	1.02	0.41	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	64.24	16.43	0.50	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	72.61	32.43	0.35	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.79	18.92	3.05	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	64.01	32.79	0.79	0.20	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	62.71	27.42	2.79	0.76	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.61	31.01	3.38	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.60	30.73	2.58	1.55	0.00	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	23.92	26.19	2.28	1.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	30.66	2.04	0.88	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	35.33	37.92	2.37	1.94	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	31.70	25.02	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.94	19.42	0.71	1.18	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.84	31.18	1.29	0.80	0.00	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	26.26	1.35	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	61.81	29.89	0.47	0.94	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	59.45	20.14	0.98	0.98	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	32.29	14.84	2.62	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.07	37.04	2.67	0.95	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.78	21.37	2.18	1.31	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	9.50	12.99	2.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	23.74	29.39	1.51	0.57	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.47	24.55	1.82	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.69	30.38	1.25	0.31	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	31.84	23.35	1.14	0.65	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	41.22	32.80	1.74	0.87	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	36.77	26.01	2.69	1.79	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	58.56	27.16	1.85	0.18	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	55.63	25.39	1.71	0.00	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.46	26.95	2.04	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	40.49	18.66	2.46	1.06	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.39	27.56	0.63	0.00	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.96	25.42	3.93	0.91	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.65	15.00	0.00	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	20.59	1.33	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.44	15.39	2.31	0.00	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	35.54	19.94	1.02	0.00	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	19.69	0.00	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.89	21.17	0.67	1.34	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	65.21	28.26	0.97	0.48	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	57.49	24.51	2.67	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	62.44	39.02	2.44	1.46	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	26.59	16.81	1.83	1.53	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	6.51	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	11.25	14.56	2.32	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.18	23.53	2.19	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.33	22.07	1.09	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.57	16.01	1.78	1.42	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	13.13	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.98	22.35	1.76	0.68	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.90	17.78	1.62	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	126.64	61.75	0.48	0.73	12.11	0.24
immature langerhans cells, donor2	11905-125F6	115.65	62.58	1.58	0.00	3.17	0.00
insula, adult, pool1	10039-101F3	109.40	55.83	0.57	0.57	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	205.17	48.45	0.98	0.98	0.33	0.65
kidney, adult, pool1	10017-101C8	230.49	50.86	4.01	0.60	1.70	0.40
kidney, fetal, pool1	10045-101F9	178.54	47.89	0.99	0.28	1.98	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	75.70	60.07	0.14	0.14	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	54.74	18.66	0.83	0.69	1.11	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.54	7.52	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	235.92	67.56	3.81	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	307.44	44.50	3.03	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	3.83	12.31	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	164.54	43.83	5.75	2.16	0.36	2.51
leiomyoma cell line:15242A	10570-108B3	111.96	30.43	3.80	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	139.38	47.59	7.28	0.73	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	81.55	37.64	2.09	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.38	27.27	0.59	0.12	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	71.70	37.33	0.94	0.00	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	48.74	26.44	0.37	0.12	0.12	0.00
liver, adult, pool1	10018-101C9	98.70	23.66	4.54	0.32	0.16	0.81
liver, fetal, pool1	10086-102B5	38.57	20.70	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	22.89	11.23	0.00	0.00	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	25.84	14.21	0.37	0.18	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	24.26	15.24	0.56	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	18.93	11.78	0.42	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	44.15	34.05	0.14	0.28	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	188.90	39.30	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	149.22	57.60	0.66	0.53	0.40	0.13
lung, adult, pool1	10019-101D1	183.45	49.50	3.78	0.71	0.47	0.95
lung, fetal, donor1	10068-101I5	227.18	51.66	3.14	0.29	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	233.23	66.44	6.87	2.29	0.00	0.92
lymph node, adult, donor1	10077-102A5	141.54	68.64	0.95	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	33.32	27.40	0.00	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	134.48	28.22	1.21	0.75	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	93.44	11.04	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	308.13	64.38	1.78	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	225.79	44.62	2.70	1.66	0.00	0.21
mature adipocyte, donor3	12233-129G1	234.69	40.54	3.32	1.19	0.24	1.42
mature adipocyte, donor4	12234-129G2	111.08	38.43	0.53	0.79	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	132.71	45.27	0.95	0.95	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	53.02	25.94	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	98.21	31.26	1.29	0.55	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	65.13	28.91	0.64	0.00	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	5.12	5.54	0.43	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	77.12	37.29	1.86	0.68	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	83.19	34.17	1.27	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	42.38	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.33	7.90	0.36	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	51.27	18.82	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	58.98	26.78	1.08	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	59.59	25.79	0.41	0.08	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	47.91	18.40	1.39	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	59.34	29.67	1.33	0.44	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	26.29	22.87	0.12	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	64.54	30.47	1.72	0.43	0.00	1.44
melanoma cell line:G-361	10465-106H6	43.16	28.23	2.17	0.81	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	156.48	36.54	5.79	0.36	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	24.67	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	22.81	5.96	0.52	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	111.39	51.25	1.69	0.61	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	64.71	37.63	1.45	0.18	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	113.46	40.17	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	93.56	36.24	1.40	0.14	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	104.56	33.89	1.35	0.19	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	183.24	39.56	4.86	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	72.94	18.36	2.06	0.86	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	151.94	36.34	1.50	0.81	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	73.48	31.30	0.93	0.13	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	62.79	27.95	0.95	0.14	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	68.29	32.15	0.71	0.43	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	31.95	28.32	0.00	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.24	32.66	0.83	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	115.20	44.68	2.44	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	65.74	28.17	1.22	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	66.50	36.66	1.08	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	91.14	47.17	1.55	0.31	0.10	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	145.69	22.80	3.88	0.91	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	88.11	30.63	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.61	26.90	0.90	0.00	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	74.40	38.86	1.14	0.35	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	56.33	36.45	2.21	0.00	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	70.97	31.19	2.86	0.29	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.26	28.63	0.42	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	147.50	42.01	3.65	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	144.77	40.41	3.58	1.28	0.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	162.81	44.50	2.09	2.09	0.52	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	166.98	45.60	4.31	0.92	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	152.04	41.89	3.06	0.71	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	161.11	44.68	2.71	1.35	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	186.66	46.76	1.18	1.57	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	181.18	47.27	2.32	0.00	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	289.82	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	182.57	48.74	3.17	1.44	2.02	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	178.93	40.60	1.34	0.89	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	181.71	49.27	2.64	0.96	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	194.33	56.47	0.73	1.47	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	159.10	42.63	5.71	1.34	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	178.49	45.03	4.50	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	163.23	42.96	2.15	0.86	0.86	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	172.27	43.75	8.20	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	25.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	120.50	37.68	6.17	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	136.77	37.83	5.82	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	134.34	53.31	4.26	0.00	2.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	131.66	35.16	2.45	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	128.67	36.54	5.05	0.78	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	119.63	48.27	2.10	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	134.12	36.76	4.97	1.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	109.65	47.67	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	125.12	47.44	3.56	0.59	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	124.28	46.30	4.87	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	149.48	49.40	5.07	0.00	0.63	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	101.06	30.70	1.03	1.03	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	98.86	30.09	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	107.78	27.94	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	34.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	71.31	38.30	2.04	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	73.09	35.75	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	58.95	33.01	2.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	60.47	37.72	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	50.79	38.76	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	78.06	43.76	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	33.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	64.71	33.04	1.38	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	53.44	25.73	0.99	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	34.77	14.58	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.80	28.62	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	74.55	20.15	0.40	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	30.53	2.18	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	62.09	19.01	0.00	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	60.08	16.99	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.95	15.65	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	38.49	17.26	0.60	0.20	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	48.35	24.01	1.30	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	59.08	28.52	2.04	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	75.05	45.65	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	67.57	47.72	0.47	0.24	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	165.18	31.28	0.23	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	269.24	76.92	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	140.05	45.83	4.42	0.82	0.31	0.31
mesothelioma cell line:Mero-25	10850-111F4	81.02	14.53	1.36	0.00	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	145.22	44.49	1.96	0.49	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	179.36	54.03	2.44	0.66	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	89.35	17.87	1.05	0.79	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	135.16	39.66	3.74	1.02	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	273.25	66.23	5.06	1.26	1.52	0.25
mesothelioma cell line:Mero-95	10856-111G1	189.44	40.79	2.07	0.62	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	187.84	45.72	1.99	0.83	1.16	0.66
mesothelioma cell line:NCI-H226	10846-111E9	174.48	27.15	2.35	1.45	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	146.57	44.07	2.90	0.51	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	91.86	78.12	1.27	0.51	0.51	0.25
mesothelioma cell line:No36	10857-111G2	114.82	33.93	0.33	0.65	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	236.81	57.98	4.61	1.08	1.63	0.54
migratory langerhans cells, donor1	11901-125F2	103.45	63.91	3.07	2.11	0.58	1.15
migratory langerhans cells, donor2	11902-125F3	178.04	73.27	1.71	0.61	1.83	0.00
migratory langerhans cells, donor3	11903-125F4	104.64	82.92	1.62	0.36	1.26	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	55.17	10.77	0.65	0.33	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	69.73	35.18	1.27	0.42	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	351.53	46.30	0.46	0.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	228.92	85.82	2.28	1.33	0.76	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	131.94	63.38	1.11	0.55	0.18	0.00
myeloma cell line:PCM6	10474-106I6	112.08	13.05	0.99	0.20	0.00	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	119.72	66.45	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	104.35	28.05	0.20	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.10	9.58	0.33	0.22	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.21	8.68	0.44	0.22	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	78.38	20.42	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	2.53	1.61	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	55.75	44.90	0.19	0.37	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	13.29	5.27	0.21	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	28.88	21.24	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.59	25.15	0.47	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.40	24.23	1.11	0.16	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	46.69	19.92	0.20	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.78	21.62	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	134.15	49.77	0.53	0.80	1.06	0.27
neutrophil PMN, donor1	12133-128D9	1338.73	401.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	292.17	79.68	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	227.30	66.29	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	99.95	14.71	0.34	0.34	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	21.61	3.20	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	76.95	35.91	0.64	0.96	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	158.71	45.20	4.47	1.05	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	92.43	41.71	0.19	0.19	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	63.87	20.60	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	91.51	34.08	0.27	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	24.02	22.56	1.09	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	69.01	37.00	4.46	0.26	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	5.58	6.01	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	97.61	37.37	0.47	0.39	0.16	0.08
olfactory region, adult	10195-103E6	77.19	29.80	1.72	0.57	0.00	0.19
optic nerve, donor1	10277-104E7	38.02	8.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	121.08	22.44	0.91	0.23	0.23	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	272.16	88.06	0.96	1.10	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	149.85	27.26	3.39	1.35	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	96.22	39.73	1.16	0.69	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	73.20	55.85	1.18	0.59	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	73.81	67.27	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	42.20	15.90	0.85	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	134.17	54.16	3.58	0.44	0.17	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.96	22.92	0.18	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	126.99	30.10	1.88	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	55.35	23.20	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	116.18	18.57	3.24	0.51	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	304.01	35.27	0.99	0.99	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	86.67	35.33	0.55	0.09	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	57.99	32.30	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	44.20	21.63	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	95.77	40.76	0.86	0.00	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	91.03	37.54	0.44	0.26	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	9.70	13.58	0.00	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	18.32	14.21	0.00	0.37	0.00	0.37
parotid gland, adult	10199-103F1	105.45	32.07	0.00	0.00	0.00	1.23
penis, adult	10200-103F2	200.88	37.60	3.22	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.61	14.32	0.37	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	173.52	22.29	1.46	0.58	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	70.95	30.96	0.00	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	56.85	33.76	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	61.45	36.37	1.25	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	29.34	15.18	0.00	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	46.91	12.51	0.00	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	15.32	8.51	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	163.73	51.60	1.61	0.32	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	58.67	32.58	0.26	0.53	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	36.73	13.70	0.16	0.31	0.00	0.00
pons, adult, pool1	10033-101E6	40.54	21.69	0.17	0.00	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	94.32	42.19	0.35	0.00	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	460.11	355.54	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	77.11	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	82.15	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	87.98	42.82	0.87	0.15	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	332.15	110.90	0.91	0.91	0.36	0.00
prostate, adult, pool1	10022-101D4	160.16	49.34	3.45	1.00	0.09	0.27
putamen, adult, donor10196	10176-103C5	102.45	45.56	0.71	0.71	0.00	0.24
putamen, adult, donor10252	10152-102I8	68.63	27.45	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	46.99	16.39	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	99.79	37.93	0.97	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	8.25	11.99	3.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	164.38	45.39	0.29	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	153.01	118.23	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	73.56	39.64	0.64	0.21	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	40.59	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	109.74	45.23	1.19	0.50	0.50	0.20
retinoblastoma cell line:Y79	10475-106I7	14.03	23.64	0.00	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.43	16.11	0.12	0.12	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	49.77	33.74	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	129.59	77.30	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	58.27	21.69	1.46	0.16	0.00	0.49
salivary acinar cells, donor2	11772-123I8	77.79	19.28	1.93	0.41	0.00	0.14
salivary acinar cells, donor3	11773-123I9	99.97	19.20	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	136.12	26.31	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.18	43.93	0.59	0.17	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.55	38.91	0.59	0.12	0.35	0.35
seminal vesicle, adult	10201-103F3	152.90	56.61	3.17	1.59	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	208.19	23.32	2.19	0.73	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	86.31	41.27	1.26	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	143.51	64.23	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	276.83	56.82	2.01	0.54	0.81	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	185.91	18.24	0.55	0.55	0.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	145.93	25.16	1.03	1.16	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	229.82	41.85	0.71	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	224.40	41.02	6.84	1.44	0.24	1.32
skeletal muscle, fetal, donor1	10066-101I3	92.46	42.21	1.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	81.42	74.64	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	76.38	29.04	1.26	0.63	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.35	21.35	0.67	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	7.56	3.15	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.21	58.60	0.96	0.39	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	24.23	9.40	0.16	0.00	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.31	12.87	0.32	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	135.11	18.52	1.09	0.44	0.65	0.00
small intestine, adult, pool1	10024-101D6	354.75	35.71	6.21	2.03	0.00	1.55
small intestine, fetal, donor1	10064-101I1	93.36	39.80	1.97	0.00	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	188.75	30.77	2.05	2.05	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	133.62	39.80	1.03	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	85.77	19.30	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	33.72	20.19	0.23	0.23	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	56.77	28.39	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	25.60	12.45	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	50.62	29.27	0.61	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	14.24	14.69	1.38	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	131.88	49.59	0.15	0.45	1.64	0.15
spleen, adult, pool1	10025-101D7	104.85	53.19	3.52	0.44	0.22	0.33
spleen, fetal, pool1	10044-101F8	94.00	42.59	0.64	0.24	0.56	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.92	50.00	0.62	0.10	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	133.67	18.04	0.76	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	173.33	49.62	4.19	1.05	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	105.55	16.03	1.17	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	131.02	13.39	0.68	0.11	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.65	13.13	0.42	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	86.73	50.35	0.85	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	247.77	64.08	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	110.52	29.05	5.13	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	33.65	17.03	0.62	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	22.76	9.83	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.85	22.61	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.91	62.13	0.69	1.15	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	116.73	49.93	1.02	0.08	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.14	11.40	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	11.87	0.88	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	140.69	44.68	2.79	1.40	0.70	0.35
tenocyte, donor2	11765-123I1	177.78	44.64	2.29	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	183.85	39.66	3.71	0.37	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.30	24.98	0.17	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	32.83	15.11	0.62	0.31	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	31.62	30.07	0.15	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	70.20	16.88	0.89	0.25	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.07	9.83	0.00	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	44.50	13.31	0.87	0.22	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	81.43	28.66	2.28	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	116.93	64.42	8.05	0.86	0.11	1.93
testis, adult, pool2	10096-102C6	60.90	57.29	1.35	0.90	0.00	0.00
thalamus - adult, donor10196	10168-103B6	24.29	13.25	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	45.95	22.19	1.09	0.31	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	18.48	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	40.68	22.07	0.99	0.49	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	10.93	6.90	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	261.90	32.96	5.74	2.25	0.00	0.75
throat, fetal, donor1	10061-101H7	98.12	49.06	0.91	1.22	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	39.15	24.44	0.79	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	290.19	55.67	7.26	1.89	0.40	1.59
thymus, fetal, pool1	10043-101F7	217.37	37.82	2.08	0.52	0.31	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	52.25	27.26	0.93	0.13	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	58.25	23.33	1.12	0.00	0.56	0.00
thyroid, adult, pool1	10028-101E1	118.51	36.58	2.15	0.56	0.09	0.28
thyroid, fetal, donor1	10060-101H6	86.22	36.12	1.05	0.79	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	252.53	49.27	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	213.04	29.77	5.35	1.63	0.47	2.09
tongue, fetal, donor1	10059-101H5	189.95	42.96	1.97	1.58	0.79	0.00
tonsil, adult, pool1	10047-101G2	239.52	35.96	1.00	0.40	0.60	0.20
trachea, adult, pool1	10029-101E2	201.88	42.04	2.62	0.74	0.57	0.74
trachea, fetal, donor1	10058-101H4	127.72	33.47	2.31	1.15	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	216.11	61.29	2.13	0.00	1.42	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	87.13	19.55	0.71	0.41	0.30	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	120.49	103.41	2.66	0.94	0.00	0.63
tridermal teratoma cell line:HGRT	10694-109G1	121.76	100.83	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	182.34	37.08	1.02	0.51	0.59	0.08
umbilical cord, fetal, donor1	10057-101H3	131.45	64.68	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	132.41	48.29	1.37	0.34	0.34	0.00
uterus, fetal, donor1	10055-101H1	56.82	69.11	0.00	0.00	0.51	0.00
vagina, adult	10204-103F6	213.89	33.60	2.58	0.00	0.00	0.65
vein, adult	10191-103E2	171.41	49.54	5.26	1.53	0.22	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	43.53	47.53	1.07	0.00	0.00	0.00